Enanta Pharmaceuticals Aktie
11,40
EUR
±0,00
EUR
±0,00
%
13,86
USD
+0,01
USD
+0,07
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
| 24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
| 02.01.18 | Enanta Pharmaceuticals Sector Perform | RBC Capital Markets | |
| 21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 07.08.15 | Enanta Pharmaceuticals Equal weight | Barclays Capital | |
| 06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG | |
| 04.03.15 | Enanta Pharmaceuticals Equal weight | Barclays Capital |
Werbung
Werbung